Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis
@article{ATM67139, author = {Xueshan Sun and Xuemei Zhen and Xiaoqian Hu and Yuanyuan Li and Shuyan Gu and Yuxuan Gu and Zixuan Zhao and Wei Yang and Hengjin Dong}, title = {Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis}, journal = {Annals of Translational Medicine}, volume = {9}, number = {7}, year = {2021}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/67139} }